BTBD7 and hepatocellular carcinoma: Data from TCGA database showed that patients with high BTBD7 expression had a poor prognosis in overall survival (Figure 3(a)), and immunohistochemical staining carried out in all 87 paired HCC sample also confirmed that BTBD7 was highly expressed in tumor tissues of NSCLC (Figure 3(b)).